• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neuraxis, Inc. Common Stock (NY:NRXS)

7.000 -0.510 (-6.79%)
Official Closing Price Updated: 8:00 PM EDT, Mar 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 118,874
Open 7.470
Bid (Size) 6.950 (100)
Ask (Size) 7.000 (6,500)
Prev. Close 7.510
Today's Range 6.820 - 7.470
52wk Range 1.330 - 7.970
Shares Outstanding 10,652,812
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NeurAxis Inc (NYSEARCA:NRXS) Reports Q4 Revenue Beat Amid Mixed Market Reaction ↗
March 19, 2026
Via Chartmill
Neuraxis Inc (NRXS) Shows High Growth Momentum and Strong Technical Trend ↗
March 16, 2026
Via Chartmill

Performance

YTD
+57.0%
+57.0%
1 Month
+39.7%
+39.7%
3 Month
+78.6%
+78.6%
6 Month
+154.5%
+154.5%
1 Year
+225.6%
+225.6%

More News

Read More
News headline image
Which stocks are gapping on Friday? ↗
December 19, 2025
Via Chartmill
News headline image
Neuraxis Earnings Preview ↗
November 10, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
October 24, 2025
Via Benzinga
News headline image
Earnings Outlook For Neuraxis ↗
August 11, 2025
Via Benzinga
News headline image
Earnings Scheduled For May 12, 2025 ↗
May 12, 2025
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
November 12, 2024
Via Benzinga
News headline image
NRXS Stock Earnings: Neuraxis Reported Results for Q2 2024 ↗
August 09, 2024
Via InvestorPlace
News headline image
NRXS Stock Earnings: Neuraxis Reported Results for Q1 2024 ↗
May 22, 2024
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
August 28, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
July 21, 2025
Via Benzinga
News headline image
Top movers in Tuesday's after hours session ↗
May 20, 2025
Via Chartmill
News headline image
Gold Gains Over 1%; Amer Sports Posts Upbeat Earnings ↗
May 20, 2025
Via Benzinga
News headline image
NRXS Stock Earnings: Neuraxis Misses Revenue for Q4 2023 ↗
April 16, 2024
Via InvestorPlace
News headline image
Earnings Scheduled For August 12, 2025 ↗
August 12, 2025
Via Benzinga
News headline image
Nasdaq Falls 100 Points; Home Depot Sales Top Views ↗
May 20, 2025
Via Benzinga
News headline image
Earnings Scheduled For March 20, 2025 ↗
March 20, 2025
Via Benzinga
News headline image
Earnings Scheduled For April 9, 2024 ↗
April 09, 2024
Via Benzinga
With Only 1.21 Million In The Trading Float, NeurAxis Stock Volatility Exposes An Opportunity, Not A Deterrent ($NRXS)
September 19, 2023
Via AB Newswire
News headline image
EXCLUSIVE: NeurAxis' Nerve Field Stimulation Tech Shows Improved Quality of Life of Adolescents Patients With Irritable Bowel Syndrome ↗
September 12, 2023
Via Benzinga
CEO Spotlight: NeurAxis CEO Explains His Better Way Of Treating Pediatric IBS And FAP ($NRXS)
September 06, 2023
Via AB Newswire
News headline image
Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
September 12, 2023
Via Benzinga
News headline image
NeurAxis Looks To Revolutionize The Treatment Of Adolescent Stomach Issues ↗
August 30, 2023
Via Benzinga
News headline image
EXCLUSIVE: Small MedTech Firm NeurAxis Targets $2B Market With Post-Concussion Therapy In Kids ↗
August 29, 2023
Via Benzinga

Frequently Asked Questions

Is Neuraxis, Inc. Common Stock publicly traded?
Yes, Neuraxis, Inc. Common Stock is publicly traded.
What exchange does Neuraxis, Inc. Common Stock trade on?
Neuraxis, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Neuraxis, Inc. Common Stock?
The ticker symbol for Neuraxis, Inc. Common Stock is NRXS on the New York Stock Exchange
What is the current price of Neuraxis, Inc. Common Stock?
The current price of Neuraxis, Inc. Common Stock is 7.000
When was Neuraxis, Inc. Common Stock last traded?
The last trade of Neuraxis, Inc. Common Stock was at 03/26/26 08:00 PM ET
What is the market capitalization of Neuraxis, Inc. Common Stock?
The market capitalization of Neuraxis, Inc. Common Stock is 74.57M
How many shares of Neuraxis, Inc. Common Stock are outstanding?
Neuraxis, Inc. Common Stock has 75M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap